| Companies sponsors |
Leo Pharma |
| Others |
Department of Health and Social Care |
| |
Health Technology Wales (HTW) |
| |
NHS England |
| Patient carer groups |
National Eczema Society |
| Professional groups |
British Association of Dermatologists |
| |
Royal College of Physicians |
| Comparator companies |
AAH Pharmaceuticals (alitretinoin, tacrolimus) (confidentiality agreement not signed, not participating), Accord UK (tacrolimus) (confidentiality agreement not signed, not participating), Advanz Pharma (methotrexate) (confidentiality agreement not signed, not participating), Aspen (azathioprine, mycophenolate mofetil) (confidentiality agreement not signed, not participating), Cipla UK (methotrexate) (confidentiality agreement not signed, not participating) |
| |
Dexcel Pharma (ciclosporin) (confidentiality agreement not signed, not participating), Ennogen Healthcare (alitretinoin) (confidentiality agreement not signed, not participating), Hospira (methotrexate) (confidentiality agreement not signed, not participating), Leo Pharma (tacrolimus) (confidentiality agreement not signed, not participating), Medac (methotrexate) (confidentiality agreement not signed, not participating), Medihealth (tacrolimus) (confidentiality agreement not signed, not participating), Morningside Healthcare (methotrexate) (confidentiality agreement not signed, not participating), Mylan (azathioprine; ciclosporin, (confidentiality agreement not signed, not participating)mycophenolate mofetil), Nordic Pharma (methotrexate) (confidentiality agreement not signed, not participating) |
| |
Nova (azathioprine; mycophenolate mofetil) (confidentiality agreement not signed, not participating), Novartis (ciclosporin) (confidentiality agreement not signed, not participating), Orion Pharma (methotrexate) (confidentiality agreement not signed, not participating), Rosemont Pharmaceuticals (methotrexate) (confidentiality agreement not signed, not participating) |
| |
Sandoz (methotrexate,) (confidentiality agreement not signed, not participating), Santen UK (ciclosporin) (confidentiality agreement not signed, not participating), Strides Pharma (azathioprine, mycophenolate mofetil) (confidentiality agreement not signed, not participating) |
| |
Teva UK (tacrolimus) (confidentiality agreement not signed, not participating) |
| |
Tillomed Laboratories (azathioprine, mycophenolate mofetil) (confidentiality agreement not signed, not participating), Viatris (pimecrolimus) (confidentiality agreement not signed, not participating) |
| |
Stiefel Laboratories (alitretinoin) (confidentiality agreement signed, participating) |
| General commentators |
All Wales Therapeutics and Toxicology Centre |
| |
British National Formulary |
| |
Department of Health - Northern Ireland |
| |
Healthcare Improvement Scotland |
| |
Medicines and Healthcare products Regulatory Agency |
| |
Scottish Medicines Consortium |
| |
Welsh Government |
| |
Welsh Health Specialised Services Committee |